The 5 analysts offering 12-month price forecasts for Novavax Inc have a median target of 272.00, with a high estimate of 305.00 and a low estimate of 200.00. The median estimate represents a +69.49% increase from the last price of 160.48.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$3.91
Reporting Date Nov 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.